Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
about
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
Window of Opportunity Trial, P ...... Triple Negative Breast Tumors
@en
type
label
Window of Opportunity Trial, P ...... Triple Negative Breast Tumors
@en
prefLabel
Window of Opportunity Trial, P ...... Triple Negative Breast Tumors
@en
P1476
Window of Opportunity Trial to ...... o the PARP Inhibitor Rucaparib
@en
P3098
NCT03911453
P580
2019-05-01T00:00:00Z
P582
2019-11-30T00:00:00Z